Immunological aspects of minimally invasive oncologic surgery

Current Opinion in Urology

Volumn 18, Issue 2, 2008, Pages 129-133

  Hegarty, Nicholas ^a   Dasgupta, Prokar ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Immunosupression; Neutrophil apoptosis; Pneumoperitoneum

Indexed keywords

TUMOR VACCINE;

ABDOMINAL ABSCESS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; APPENDECTOMY; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; INFLAMMATION; KIDNEY CARCINOMA; LAPAROSCOPY; MINIMALLY INVASIVE SURGERY; MORBIDITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME;

CYTOKINES; HUMANS; IMMUNE SYSTEM; LAPAROSCOPY; LYMPHOCYTE SUBSETS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; UROLOGIC NEOPLASMS;

EID: 39849089739     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f517fc     Document Type: Review

References (34)

1. Fomara P, Doehn C, Seyfarth M, Jocham D. Why is urological laparoscopy minimally invasive? Eur Urol 2000; 37:241-250.
2. Dasgupta P, Challacombe B. Immunologic aspects of laparoscopy. In: Gill IS, editor. Textbook of laparoscopic urology. New York: Informa Healthcare; 2006. pp. 955-972.
3. Ni Choillean N, Redmond HP. Cell response to surgery. Arch Surg 2006; 141:1132-1140. Excellent review article covering aspects of the inflammatory response to major surgery.
4. Nadler RB, Loeb S, Clemens JQ, et al. A prospective study of laparoscopic radical nephrectomy for T1 tumors - is transperitoneal, retroperitoneal or hand assisted the best approach? J Urol 2006; 175:1230-1233. Prospective quasi-randomized study looking at the impact of surgical approach to nephrectomy and recovery from surgery.
5. Dillenburg W, Poulakis V, Skriapis K, et al. Retroperitoneoscopic versus open surgical radical nephrectomy for renal cell carcinoma in clinical stage cT2 or cT3a: quality of life, pain and reconvalescence. Eur Urol 2006; 49:314-322. Matched study comparing recovery from open and laparoscopic nephrectomy in large renal tumours.
6. Boni L, Benevento A, Rovera F, et al. Infective complications in laparoscopic surgery. Surg Infect (Larchmt) 2006; 7 (Suppl 2):S109-S111. Review article looking at comparison of surgical outcomes and postoperative complication rates across a range of general surgical procedures.
7. Novitsky YW, Litwin DE, Callery MP. The net immunologic advantage of laparoscopic surgery. Surg Endosc 2004; 18:1411-1419.
8. Corrigan M, Cahill RA, Redmond HP. The immunomodulatory effects of laparoscopic surgery. Surg Laparosc Endosc Percutan Tech 2007; 17:256-261. Review article looking at the immunological changes occurring at the cellular level following laparoscopy.
9. Matsumoto ED, Margulis V, Tunc L, et al. Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy. J Endourol 2005; 19:1140-1145.
10. Sáenz J, Asuero MS, Villafruela J, et al. Immunohumeral response during laparoscopic and open living donor nephrectomy: an experimental model. Transplant Proc 2007; 39:2102-2104. Animal study showing significant differences in inflammatory response across a range of cytokines between surgical approaches.
11. Hiki N, Shimizu N, Yamaguchi H, et al. Manipulation of the small intestine as a cause of the increased inflammatory response after open compared with laparoscopic surgery. Br J Surg 2006; 93:195-204. Experimental animal study correlating findings within the abdomen and cytokine levels to assess the impact of bowel handling during surgery on the inflammatory response to surgery.
12. Anderson JK, Matsumoto ED, Abdel-Aziz K, et al. Serum laboratory values following uncomplicated laparoscopic urological surgery. J Urol 2006; 175:167-169. Paper gives baseline values after laparoscopy of serum markers for comparison with changes that might be detected in laparoscopic surgery associated with postoperative complications.
13. Sylla P, Kirman I, Whelan RL. Immunological advantages of advanced laparoscopy. Surg Clin North Am 2005; 85:1-18.
14. Moehrlen U, Ziegler U, Boneberg E, et al. Impact of carbon dioxide versus air pneumoperitoneum on peritoneal cell migration and cell fate. Surg Endosc 2006; 20:1607-1613. This paper differs from most others in that it looks at inflammatory cell function and survival rather than just cytokine production following air and carbon dioxide pneumoperitoneum.
15. Hanly EJ, Aurora AA, Shih SP, et al. Peritoneal acidosis mediates immunoprotection in laparoscopic surgery. Surgery 2007; 142:357-364. Well-designed animal study looking at a proposed mechanism for how the pneumoperitoneum may confer immune protection during abdominal surgery.
16. 2 causes peritoneal acidosis independent of systemic pH. J Gastrointest Surg 2005; 9:1245-1251.
17. Kuebler JF, Vieten G, Shimotakahara A, et al. Acidification during carbon dioxide pneumoperitoneum is restricted to the gas-exposed peritoneal surface: effects of pressure, gas flow, and additional intraperitoneal fluids. J Laparoendosc Adv Surg Tech A 2006; 16:654-658. Simple study exploring the mechanism by which peritoneal acidosis occurs following carbon dioxide pneumoperitoneum.
18. 2 insufflation in murine model of peritonitis. Surg Endosc 2006; 20:1440-1447. Study correlates cytokine production, inflammatory cell function and overall survival following the establishment inoculation of the peritoneum with bacteria and how this is modified by carbon dioxide pneumoperitoneum.
19. Hanly EJ, Fuentes JM, Aurora AR, et al. Carbon dioxide pneumoperitoneum prevents mortality from sepsis. Surg Endosc 2006; 20:1482-1487. Paper looks to unravel at a subcellular level signalling processes involved in the immunoprotection afforded by carbon dioxide pneumoperitoneum.
20. Curet MJ. Port site metastases. Am J Surg 2004; 187:705-712.
21. Ouellette JR, Ko AS, Lefor AT. The physiologic effects of laparoscopy: applications in oncology. Cancer J 2005; 11:2-9.
22. Jingli RC, Rong C, Rubai X. Influence of colorectal laparoscopic surgery on dissemination and seeding of tumor cells. Surg Endosc 2006; 20:1759-1761. Well-designed and important paper on mechanisms involved in tumour cell implantation.
23. Tan BJ. Is carbon dioxide insufflation safe for laparoscopic surgery? A model to assess the effects of carbon dioxide on transitional-cell carcinoma growth, apoptosis, and necrosis. J Endourol 2006; 20:965-969.
24. Leng J, Lang J, Jiang Y, et al. Impact of different pressures and exposure times of a simulated carbon dioxide pneumoperitoneum environment on proliferation and apoptosis of human ovarian cancer cell lines. Surg Endosc 2006; 20:1556-1559. Comparable findings to the previous paper.
25. Jurczok A, Schneider A, Fornara P. Inhibition of tumor implantation after laparoscopy by specific oligopeptides: a novel approach to adjuvant intraperitoneal therapy to prevent tumor implantation in an animal model. Eur Urol 2007; 52:590-595. Elegant paper proposing a mechanism to prevent implantation of malignant cells during laparoscopy in the experimental animal.
26. Atzpodien J, Reitz M. Long-term maintenance therapy in interferon-alpha2a/interleukin-2-pretreated advanced renal cell carcinoma patients. Cancer Biother Radiopharm 2006; 21:206-210. Maintenance immunotherapy continues to provide medium-term responses in patients with advanced renal cell carcinoma.
27. Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Immunotherapy of renal cell carcinoma. Cancer Immunol Immunother 2007; 56:117-128. Review article covering aspects of immunotherapy including more recent progress in the form of tumour vaccine.
28. Ramsey S, Lamb GW, Aitchison M, McMillan DC. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Br J Cancer 2006; 95:1076-1080. Shows that renal tumours that excite an inflammatory response carry a poorer prognosis.
29. Lamb GW, McMillan DC, Ramsey S, Aitchison M. The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. Br J Cancer 2006; 94:781-784.
30. Landman J, Olweny E, Sundaram CP, et al. Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinoma. J Urol 2004; 171:1456-1460.
31. Matin SF, Madsen LT, Wood CG. Laparoscopic cytoreductive nephrectomy: the MD Anderson Cancer Center experience. Urology 2006; 68:528-532.
32. Rabets JC, Kaouk J, Fergany A, et al. Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma. Urology 2004; 64:930-934.
33. Fagnoni FF, Zerbini A, Pelosi G, Missale G. Combination of radiofrequency ablation and immunotherapy. Front Biosci 2008; 13:369-381. Demonstrates the feasibility of combining radiofrequency ablation with immunotherapy to enhance response.
34. Den Brok MH, Sutmuller RP, Nierkens S, et al. Efficient loading of dendritic cells following cryotherapy and radiofrequency in combination with immune modulation induces antitumour immunity. Br J Cancer 2006; 95:896-905. Paper proposes an interesting means by which the immune response to probe ablative treatments can be used to augment tumour vaccines in targeted treatment for malignancy.